PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
If your stomach has been bothering you, this peptide could be a game-changer
Refer to the cited studies in the Research Studies section above for original source data
Factors such as lifestyle, health goals, medication needs, and treatment preferences can influence what Hormones influence nearly every system in the body, from energy and mood to sleep and metabolism
A small fraction of users (under 5 percent) report mild anxiety alongside sleep disruption in the first week of dosing
Easy to use questions I had were quickly answered on website chat before purchase